一名澳大利亚药商说,Trump对美国征收的关税对其业务或供应链没有产生重大影响。 An Australian drugmaker says U.S. tariffs under Trump had no major impact on its operations or supply chain.

澳大利亚一家制药公司报告说,美国最近在特朗普政府下征收的关税没有产生重大影响,尽管一些批评者将贸易措施称为“有害”措施,但该公司的业务和供应链依然稳定。 An Australian pharmaceutical company reports no significant impact from recent U.S. tariffs imposed under the Trump administration, stating its operations and supply chain remain stable despite the trade measures described as "harmful" by some critics. 该公司坚称,其定价和生产没有中断,它继续满足美国市场的需求。 The firm maintains that its pricing and production have not been disrupted, and it continues to meet demand in the American market.